BIIB
Biogen Inc.
Stock
$222.82−3.06 (−1.35%)Close Oct 1, 2026
| Gross profit (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $7.4B | −1.6% | −8.4% | −2.4% |
| Gross profit (TTM) | $7.4B |
|---|---|
| YoY | −1.6% |
| 5-year CAGR | −8.4% |
| 10-year CAGR | −2.4% |
Gross profit
| Period | Gross profit | YoY |
|---|---|---|
| 2025 | $7.5B | +1.6% |
| 2024 | $7.4B | +0.9% |
| 2023 | $7.3B | −7.5% |
| 2022 | $7.9B | −11.0% |
| 2021 | $8.9B | −23.8% |
| 2020 | $11.6B | −6.3% |
| 2019 | $12.4B | +6.8% |
| 2018 | $11.6B | +9.3% |
| 2017 | $10.6B | +6.8% |
| 2016 | $10.0B | +4.7% |
| 2015 | $9.5B | +11.6% |
| 2014 | $8.5B | +40.5% |
| 2013 | $6.1B | +22.2% |
| 2012 | $5.0B | +8.5% |
| 2011 | $4.6B | +6.2% |
| 2010 | $4.3B | +8.0% |
| 2009 | $4.0B | +8.1% |
| 2008 | $3.7B | +30.3% |
| 2007 | $2.8B | — |